CELECOR THERAPEUTICS
CeleCor Therapeutics develops a RUC-4 novel small molecule inhibitor designed to be the first point of contact treatment for segment elevated myocardial infarction. The molecule inhibitor uses a thrombolytic agent for percutaneous coronary intervention that can be administered subcutaneously by auto-injector, enabling decreased mortality and later development of heart failure.
CELECOR THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2017-01-01
Address:
Del Mar, California, United States
Country:
United States
Website Url:
http://www.celecor.com
Status:
Active
Contact:
+1 858 777 9750
Total Funding:
3.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apache Amazon Google Apps For Business Amazon Virginia Region
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.celecor.com
- Host name: ec2-35-91-131-11.us-west-2.compute.amazonaws.com
- IP address: 35.91.131.11
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
